dexmedetomidine has been researched along with Glioma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 7 (70.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Wu, H; Yan, H; Yang, H | 1 |
| Lin, N; Lin, S; Wang, J; Yu, S; Yu, T; Zhao, Y; Zuo, Z | 1 |
| Baroni, S; Benuzzi, F; Bertellini, E; Feletti, A; Marudi, A; Pavesi, G; Prontera, A; Valzania, F | 1 |
| Brokinkel, B; Ewelt, C; Maas, M; Mueller, I; Schipmann, S; Stummer, W; Suero Molina, E; Wölfer, J | 1 |
| Bevan, C; Date, A; Datoo, T; Jiang, C; Ma, D; Sanders, RD; Wang, C; Wang, G; Wu, L; Zhao, H | 1 |
| Chan, SM; Lin, YC; Liu, YT; Wu, ZF | 1 |
| Arulvelan, A; Easwer, HV; Krishnakumar, K; Manikandan, S | 1 |
| Huang, H; Luo, X; Zheng, X | 1 |
| Dai, H; Ding, T; Yan, M; Yu, L; Zhang, F; Zhong, Y | 1 |
| Dohi, S; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Takai, S; Tanabe, K | 1 |
2 trial(s) available for dexmedetomidine and Glioma
| Article | Year |
|---|---|
Dexmedetomidine inhibits unstable motor network in patients with primary motor area gliomas.
Topics: Adult; Brain Neoplasms; Dexmedetomidine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Motor Activity; Motor Cortex; Nerve Net | 2021 |
Protective effects of dexmedetomidine on brain function of glioma patients undergoing craniotomy resection and its underlying mechanism.
Topics: Adult; Brain Neoplasms; Craniotomy; Dexmedetomidine; Female; Glioma; Humans; Hypnotics and Sedatives; Male; Middle Aged; Neuroprotective Agents; Outcome Assessment, Health Care | 2016 |
8 other study(ies) available for dexmedetomidine and Glioma
| Article | Year |
|---|---|
Effects of dexmedetomidine on glioma cells in the presence or absence of cisplatin.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Cisplatin; Dexmedetomidine; Drug Combinations; Drug Synergism; Glioma; Humans; Male; Mice; Mice, Nude; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2020 |
Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil.
Topics: Adult; Anesthesia, Local; Anesthetics, Local; Brain Neoplasms; Craniotomy; Dexmedetomidine; Female; Glioma; Humans; Male; Middle Aged; Piperidines; Propofol; Remifentanil; Retrospective Studies; Wakefulness | 2017 |
Conscious sedation with dexmedetomidine compared with asleep-awake-asleep craniotomies in glioma surgery: an analysis of 180 patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Conscious Sedation; Craniotomy; Dexmedetomidine; Female; Glioma; Humans; Hypnotics and Sedatives; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Midazolam and Dexmedetomidine Affect Neuroglioma and Lung Carcinoma Cell Biology In Vitro and In Vivo.
Topics: Animals; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dexmedetomidine; Disease Models, Animal; Flow Cytometry; Fluorescent Antibody Technique; Glioma; Humans; Hypnotics and Sedatives; Lung Neoplasms; Mice; Midazolam | 2018 |
The successful application of high flow nasal cannula for awake craniotomy.
Topics: Adult; Airway Management; Analgesia; Analgesics, Opioid; Brain Neoplasms; Cannula; Conscious Sedation; Craniotomy; Dexmedetomidine; Fentanyl; Glioma; Humans; Hypnotics and Sedatives; Male; Pain, Postoperative; Treatment Outcome; Wakefulness | 2019 |
Effect of Loading Dose of Dexmedetomidine on Dynamic Cerebral Blood Flow Autoregulation in Patients With Intracranial Glial Neoplasms.
Topics: Adolescent; Adult; Case-Control Studies; Cerebrovascular Circulation; Dexmedetomidine; Female; Functional Laterality; Glioma; Homeostasis; Humans; Hyperemia; Hypnotics and Sedatives; Male; Supratentorial Neoplasms; Ultrasonography, Doppler, Transcranial; Young Adult | 2015 |
Dexmedetomidine protects against oxygen-glucose deprivation-induced injury through the I2 imidazoline receptor-PI3K/AKT pathway in rat C6 glioma cells.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blotting, Western; Cell Survival; Dexmedetomidine; Glioma; Glucose; Hypoxia-Inducible Factor 1, alpha Subunit; Idazoxan; Imidazoles; Imidazoline Receptors; Oxygen; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Repressor Proteins; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A | 2012 |
Alpha2 adrenoreceptor agonist regulates protein kinase C-induced heat shock protein 27 phosphorylation in C6 glioma cells.
Topics: Adrenergic alpha-Agonists; Alprostadil; Analysis of Variance; Animals; Bucladesine; Cell Line, Tumor; Colforsin; Cyclic AMP; Dexmedetomidine; Dinoprostone; Drug Interactions; Gene Expression Regulation, Neoplastic; Glioma; Heat-Shock Proteins; Phorbol Esters; Phosphorylation; Protein Kinase C; Rats; Serine; Time Factors | 2008 |